The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report

PURPOSE: To explore the safety and efficacy of lenvatinib in combination with trans-arterial chemoembolization (TACE) and programmed death receptor 1 (PD-1) antibody in the treatment of unresectable recurrent hepatocellular carcinoma (urHCC). PATIENTS AND METHODS: The clinical data of 16 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Chunyang, Shen, Junyi, Zhu, Xinrui, Peng, Wei, Zhang, Xiaoyun, Wen, Tianfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228745/
https://www.ncbi.nlm.nih.gov/pubmed/37260972
http://dx.doi.org/10.3389/fonc.2023.1096955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228745/
https://www.ncbi.nlm.nih.gov/pubmed/37260972
http://dx.doi.org/10.3389/fonc.2023.1096955

Ejemplares similares